Literature DB >> 6689958

Extracellular Ca2+ dependence and diltiazem inhibition of contraction in rabbit conduit arteries and mesenteric resistance vessels.

C Cauvin, K Saida, C van Breemen.   

Abstract

The dependence of norepinephrine-(NE-) and high potassium (80 mM K) depolarization-induced contractions on extracellular versus intracellular calcium (Ca2+) pools was studied in strips of rabbit superior mesenteric artery and its branches, and in perfused mesenteric resistance vessels. 80 mM K contractions were abolished in the presence of 0 Ca2+ 2 mM EGTA in all arteries studied, whereas 10(-5) M NE-induced contractions and stimulated 45Ca efflux in 0 Ca2+ 2 mM EGTA decreased in a graded fashion from proximal to distal arteries. These data indicate a decreasing release of intracellular Ca2+ and an increasing dependence on extracellular Ca2+ for NE-induced contractions as one proceeds from proximal to distal arteries. This pattern was paralleled by increasing sensitivity of NE-induced contractions to inhibition by diltiazem (10(-9)-10(-4) M) from proximal to distal arteries, while inhibition of 80 mM K contractions was similar in all vessels. 45Ca influx induced by 10(-5) M NE in the resistance vessels, wherein the NE does not release intracellular Ca2+, is approximately 10,000-fold more sensitive to the action of diltiazem than that in the aorta. However, when the aorta is activated by 10(-8) M NE, it becomes more sensitive to inhibition by diltiazem than when it is activated by 10(-5) M NE. The former NE concentration does not release intracellular Ca2+ in the aorta, whereas the latter does. Thus, it appears that NE-induced 45Ca influx is most susceptible to inhibition by diltiazem when the NE has not also released intracellular Ca2+. We suggest that the release of intracellular Ca2+ by NE may make its stimulated Ca2+ influx less susceptible to inhibition by diltiazem.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6689958     DOI: 10.1159/000158491

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  8 in total

1.  The effects of nifedipine on alpha 2-adrenoceptor-mediated contractions in several isolated blood vessels from the rabbit.

Authors:  W R Dunn; C J Daly; J C McGrath; V G Wilson
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

2.  Vasorelaxant properties of norbormide, a selective vasoconstrictor agent for the rat microvasculature.

Authors:  S Bova; L Trevisi; P Debetto; L Cima; M Furnari; S Luciani; R Padrini; G Cargnelli
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Preferential antagonism by diltiazem of alpha 2-adrenoceptor mediated vasoconstrictor responses in perfused tail arteries of spontaneous hypertensive rats.

Authors:  P E Hicks; C Tierney; S Z Langer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

4.  Noradrenaline modulation of calcium channels in single smooth muscle cells from rabbit ear artery.

Authors:  C D Benham; R W Tsien
Journal:  J Physiol       Date:  1988-10       Impact factor: 5.182

Review 5.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

6.  Pharmacological properties of alpha 1-adrenoceptor-mediated vasoconstrictions in dog and monkey lingual arteries: evidence for subtypes of alpha 1-adrenoceptors.

Authors:  R Skrbic; S Chiba
Journal:  Heart Vessels       Date:  1992       Impact factor: 2.037

7.  The sources of calcium for carbachol-induced contraction in the circular smooth muscle of guinea-pig stomach.

Authors:  A B Parekh; A F Brading
Journal:  Br J Pharmacol       Date:  1991-10       Impact factor: 8.739

8.  Endothelial Nitric Oxide Suppresses Action-Potential-Like Transient Spikes and Vasospasm in Small Resistance Arteries.

Authors:  Josh F Smith; Hamish A L Lemmey; Lyudmyla Borysova; C Robin Hiley; Kim A Dora; Christopher J Garland
Journal:  Hypertension       Date:  2020-07-27       Impact factor: 10.190

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.